NasdaqGM - Nasdaq Real Time Price USD
Lexeo Therapeutics, Inc. (LXEO)
2.9000
+0.1800
+(6.62%)
As of 12:56:59 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 311,413 | 11 |
| Sales | 15,319 | 9 |
| Net Shares Purchased (Sold) | 296,094 | 20 |
| Total Insider Shares Held | 249.91k | -- |
| % Net Shares Purchased (Sold) | -639.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 2.77 per share. | Direct | 2,979 | May 16, 2025 |
| ROBERTSON JENNY Officer | Sale at price 2.77 per share. | Direct | 1,445 | May 16, 2025 |
| ADLER ERIC Officer | Sale at price 2.77 per share. | Direct | 1,623 | May 16, 2025 |
| SEE TAI SANDI Officer | Sale at price 2.77 per share. | Direct | 1,018 | May 16, 2025 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Stock Award(Grant) at price 2.61 per share. | Direct | 5,554 | Mar 14, 2025 |
| ROBERTSON JENNY Officer | Stock Award(Grant) at price 2.61 per share. | Direct | 14,929 | Mar 14, 2025 |
| SEE TAI SANDI Officer | Stock Award(Grant) at price 2.61 per share. | Direct | 14,929 | Mar 14, 2025 |
| OTERO JOSE MANUEL Chief Technology Officer | Stock Award(Grant) at price 2.61 per share. | Direct | 14,929 | Mar 14, 2025 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 4.41 per share. | Direct | 19,091 | Feb 19, 2025 |
| ROBERTSON JENNY Officer | Sale at price 4.41 per share. | Direct | 9,272 | Feb 19, 2025 |
| ADLER ERIC Officer | Sale at price 4.41 per share. | Direct | 10,410 | Feb 19, 2025 |
| SEE TAI SANDI Officer | Sale at price 4.41 per share. | Direct | 6,558 | Feb 19, 2025 |
| RASBACH KYLE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| ROBERTSON JENNY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| ADLER ERIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| SEE TAI SANDI Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| OTERO JOSE MANUEL Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 8.20 per share. | Direct | 20,491 | Dec 10, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.33 per share. | Direct | 5,825 | Dec 10, 2024 |
| CHOLMONDELEY PAULA H. J. Director | Purchase at price 6.99 per share. | Direct | 104,852 | Nov 25, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 7.82 per share. | Direct | 19,557 | Nov 11, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.33 per share. | Direct | 5,825 | Nov 11, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 8.10 per share. | Direct | 40,496 | Oct 10, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.33 per share. | Direct | 11,650 | Oct 10, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 10.65 per share. | Direct | 53,274 | Sep 10, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.33 per share. | Direct | 11,650 | Sep 10, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 11.53 per share. | Direct | 57,634 | Aug 12, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.33 per share. | Direct | 11,650 | Aug 12, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 16.45 - 19.06 per share. | Direct | 923,388 | Jul 11, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.33 per share. | Direct | 11,650 | Jul 10, 2024 |
| OTERO JOSE MANUEL Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 17.29 - 18.18 per share. | Direct | 88,264 | Jun 10, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.33 per share. | Direct | 11,650 | Jun 10, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Sale at price 13.22 per share. | Direct | 66,093 | May 13, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.33 per share. | Direct | 11,650 | May 13, 2024 |
| ADLER ERIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 2, 2024 |
| TOWNSEND RICHARD NOLAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2024 |
| ROBERTSON JENNY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2024 |
| LUNDBECKFOND INVEST AS Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.00 per share. | Direct | 2,499,992 | Nov 7, 2023 |
| LUNDBECKFOND INVEST AS Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Nov 7, 2023 |
| OMEGA FUND VI, L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.00 per share. | Direct | 4,999,995 | Nov 7, 2023 |
| OMEGA FUND VI, L.P Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Nov 7, 2023 |
| LONGITUDE CAPITAL PARTNERS IV, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.00 per share. | Indirect | 4,999,995 | Nov 7, 2023 |
| LONGITUDE CAPITAL PARTNERS IV, L.L.C. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 7, 2023 |
| MCCORMAC PAUL Chief Technology Officer | -- | Direct | -- | Nov 7, 2023 |
Related Tickers
TRVI Trevi Therapeutics, Inc.
5.94
-6.02%
TSHA Taysha Gene Therapies, Inc.
2.8850
+3.59%
MLTX MoonLake Immunotherapeutics
48.45
+17.70%
KROS Keros Therapeutics, Inc.
15.11
+3.07%
IMTX Immatics N.V.
6.01
0.00%
ITOS iTeos Therapeutics, Inc.
10.16
+1.46%
NGNE Neurogene Inc.
18.77
+5.75%
COGT Cogent Biosciences, Inc.
5.74
+2.32%
QURE uniQure N.V.
15.02
+3.66%
SVRA Savara Inc.
2.3750
-1.04%